。CAR088 是一种靶向 BCMA 的新型二代以 4-1BB 为共刺激分子的 CAR-T 细胞，BCMA 在多发性骨髓瘤（MM）细胞上特异性高表达。C-CAR088 采用

, Bready BB. Turbidimetric assessment of the compatibility of taxol with selected

(Resonium A/Kayexalate) in a burn patient. Burns 28:189–190, 2002.[15] Gerstman BB

Pharm 1993; 50:2359-63.23. Trissel LA, Bready BB. Turbidimetric assessment

抗肿瘤方案。未来，输入 TIL 后进行 T 细胞检查点阻断干预，将会是一种潜在提高反应率、延长生存期的有效方法。另一个好消息是， CD8 TIL 表达的 4-1BB

（T细胞受体）的结合，另一个来自共刺激分子(OX40，4-1BB)和共抑制分子PD-L1／PD-1等信号传递（图2）。因此，针对PD．1／PD．L1的单抗可以阻断

PF-05082566是Pfizer研发的anti-4-1BB单抗，I期试验（NCT01307267）入组了27例晚期实体瘤患者，包括11例结直肠癌、6例Merkel

。PDGF是目前发现的促HSC增殖最有效的因子，尤以PDGF-BB对HSC的增殖作用最强。最近研究认为，PDGF能够直接使HSC增殖并向肌成纤维细胞转化，促进转化的

看书，到晚上6,7点回到家，随便吃点面条（因为那段时间家里人有事没时间来照顾我这个孕妇，所以我跟我老公整天就是自己煮肉丸面，省时间并且卫生，真是委屈我的BB

会议简介

According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.

Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..

IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

Register Now

PAYMENT TERMS

Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.

Payments by Singapore Dollars (S$)

Payments by RMB (CNY)

• Payment by telegraphic transfer in CNY must be made to:
  A/C Name:
  A/C No.: 720-031103-001
  Beneficiary Bank:
  Bank Address: No. 1000 Lujiazui Rind Road,
  Pudong, Shanghai 200120, P.R. China
  Bank Swift Code: HSBCCNSH

CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.

Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.


DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.

、溴结构域蛋白BET等也开展了大量基础研究。近来抗癌领域最耀眼的无疑是免疫疗法，调节CTLA4、PD1/PDL1、4-1BB、OX40、CD27等...经典的抑制性信号通路是PD1和CTLA4，2014年OX40、CD27、CD137(4-1BB)三条共刺激信号而逐渐进入临床开发。由于

这一期《月度好文精选》来晚啦，因为药药忙着处理「专业版拼团」活动的用户反馈。虽然晚了一些，但我保证，这一期好文章绝对超值！8 月用药经验 TOP 5《临床医生...给药？》《五张表教你同类药物如何等效剂量换算》8 月用药问答 TOP 5《用药问答：输液时突然休克，谁是罪魁祸首？》《用药问答：急诊遇糖尿病急性并发症

2017 年 6 月 13 日，备受瞩目的 2016 SCI 期刊影响因子正式发布，儿科领域的各期刊的 IF 值有何变化？一起来看下吧。儿科领域 Top 10...。儿科领域Top 30至于第 19 名，儿科君搜了去年的前 50 也没找到，只能说是一匹黑马。。。具体查询方法进入网站：web of science